Ji Hoe Heo Selected Research

danaparoid (Orgaran)

11/2019	Brachial-ankle pulse wave velocity for predicting functional outcomes in patients with cryptogenic stroke.
12/2016	Histologic features of acute thrombi retrieved from stroke patients during mechanical reperfusion therapy.
8/2014	Brachial-ankle pulse wave velocity for predicting functional outcome in acute stroke.
11/2012	Long-term mortality in patients with stroke of undetermined etiology.
11/2010	Stroke severity in concomitant cardiac sources of embolism in patients with atrial fibrillation.
4/2010	Transoesophageal echocardiography in patients with acute stroke with sinus rhythm and no cardiac disease history.
6/2009	Cardiac computed tomographic angiography for detection of cardiac sources of embolism in stroke patients.
1/2007	A new subtype classification of ischemic stroke based on treatment and etiologic mechanism.
1/2007	Frequency and significance of cardiac sources of embolism in the TOAST classification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji Hoe Heo Research Topics

Disease

86	Stroke (Strokes) 01/2022 - 06/2003
54	Ischemic Stroke 01/2022 - 10/2004
17	Thrombosis (Thrombus) 07/2022 - 05/2003
11	Atrial Fibrillation 01/2022 - 03/2015
8	Cerebral Infarction 11/2021 - 08/2012
8	Infarction (Infarctions) 03/2020 - 07/2005
6	Atherosclerosis 11/2021 - 05/2008
6	Hemorrhage 01/2021 - 11/2010
6	Brain Ischemia (Cerebral Ischemia) 05/2020 - 06/2011
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2020 - 05/2007
6	Embolism (Embolus) 08/2015 - 01/2007
5	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 11/2021 - 12/2013
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 05/2014
4	Transient Ischemic Attack 01/2022 - 03/2015
4	Myocardial Infarction 01/2021 - 11/2010
4	Pathologic Constriction (Stenosis) 01/2015 - 01/2007
3	Neoplasms (Cancer) 10/2021 - 01/2019
3	Brain Edema (Cerebral Edema) 03/2020 - 07/2005
3	Inflammation (Inflammations) 01/2020 - 12/2012
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 10/2017
3	Cerebral Hemorrhage 04/2018 - 01/2016
3	Hypertension (High Blood Pressure) 01/2018 - 01/2009
2	Vascular Diseases (Vascular Disease) 02/2021 - 05/2008
2	Unstable Angina 01/2019 - 10/2017
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2016 - 04/2013
2	Neurologic Manifestations (Neurological Manifestations) 07/2015 - 05/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2015 - 01/2013
2	Carotid Stenosis (Carotid Artery Stenosis) 09/2013 - 10/2011
2	Ischemia 08/2013 - 01/2012
2	Vascular System Injuries 12/2012 - 05/2008
1	Leukopenia 10/2021
1	Moyamoya Disease (Moya-Moya Disease) 09/2021
1	Out-of-Hospital Cardiac Arrest 01/2021
1	COVID-19 01/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2019
1	Overweight 01/2019
1	Apnea 01/2019
1	Cognitive Dysfunction 05/2018

Drug/Important Bio-Agent (IBA)

11	AnticoagulantsIBA 07/2021 - 06/2011
9	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 11/2010
9	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 10/2004
9	danaparoid (Orgaran)FDA Link 11/2019 - 01/2007
6	Escitalopram FDA Link 11/2021 - 01/2017
6	Vitamin K FDA Link 07/2021 - 05/2016
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2012
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2020 - 10/2005
5	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2013
5	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 06/2003
4	Indicators and Reagents (Reagents)IBA 09/2021 - 09/2012
4	omega-Chloroacetophenone (Mace)IBA 01/2021 - 10/2017
4	CalciumIBA 01/2020 - 09/2013
3	ferric chlorideIBA 11/2021 - 01/2013
3	N(4)-oleylcytosine arabinosideIBA 07/2021 - 01/2018
3	salicylhydroxamic acid (SHAM)IBA 03/2020 - 05/2007
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2016
3	Dabigatran FDA Link 01/2020 - 10/2017
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016 - 10/2004
3	ImmunosorbentsIBA 08/2013 - 06/2003
3	EnzymesIBA 08/2013 - 06/2003
2	FibrinIBA 11/2021 - 12/2016
2	Serotonin (5 Hydroxytryptamine)IBA 11/2021 - 01/2018
2	Fc-saxatilinIBA 01/2020 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2019 - 08/2013
2	Pharmaceutical PreparationsIBA 01/2018 - 04/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017 - 01/2016
2	Evans Blue (Blue, Evans)FDA Link 01/2017 - 07/2015
2	Alkaline PhosphataseIBA 03/2014 - 12/2013
2	Phosphates (Orthophosphate)IBA 03/2014 - 12/2013
2	OsteoprotegerinIBA 08/2013 - 12/2012
2	Therapeutic UsesIBA 01/2013 - 05/2008
2	GelatinIBA 01/2012 - 05/2004
1	Blood Coagulation Factors (Coagulation Factor)IBA 07/2022
1	Interleukin-17 (Interleukin 17)IBA 07/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2022
1	ResistinIBA 11/2021
1	Antidepressive Agents (Antidepressants)IBA 11/2021
1	Saline SolutionIBA 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021
1	Retinaldehyde (Retinal)IBA 09/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2021
1	Testosterone (Sustanon)FDA Link 02/2021
1	Biological ProductsIBA 01/2021
1	Aquaporin 4IBA 03/2020
1	Acetazolamide (Diamox)FDA LinkGeneric 03/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	RivaroxabanIBA 01/2020
1	trimethyloxamine (trimethylamine N-oxide)IBA 09/2019
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018

Therapy/Procedure

28	Therapeutics 01/2022 - 08/2005
18	Thrombectomy 01/2021 - 07/2015
12	Stents 01/2020 - 10/2011
5	Thrombolytic Therapy 09/2013 - 01/2006
3	Secondary Prevention 10/2017 - 01/2014
2	Punctures 01/2021 - 01/2016
1	Wearable Electronic Devices 01/2022
1	Induced Hypothermia 01/2021
1	Catheters 11/2018
1	Treatment Delay 01/2018